×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sales of Roche's juggernaut Vabysmo rout the analyst consensus
Fierce Pharma
It's been eight months since Regeneron secured approval for a high-dose version of its powerhouse macular degeneration treatment Eylea in...
12 hours ago
Making the Grade: 20 LI students qualify for Regeneron International Science and Engineering Fair
Newsday
Twenty Long Island students have qualified for the Regeneron International Science and Engineering Fair in Los Angeles next month,...
12 hours ago
Los Alamos High School's Dr. Michela Ombelli Honored As 2024 Regeneron Science Talent Search Teacher Of Merit
Los Alamos Daily Post
Los Alamos High School (LAHS) Science Teacher Dr. Michela Ombelli has been awarded a 2024 Teacher of Merit Certificate by the Regeneron...
13 hours ago
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Yahoo Finance UK
Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), Regeneron Pharmaceuticals,...
8 hours ago
Regeneron to defend against DOJ complaint on drug-price manipulation
Reuters
Regeneron Pharmaceuticals said on Monday it seeks to defend against U.S. Department of Justice's complaint that alleged the company...
1 week ago
Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
Shares of Regeneron Pharmaceuticals Inc. shed 0.80% to $893.99 Thursday, on what proved to be an all-around mixed trading session for the...
6 days ago
US Intensifies Drug Discount Debate in Latest Regeneron Lawsuit
Bloomberg Law News
New Justice Department allegations that Regeneron Pharmaceuticals Inc. artificially inflated Medicare reimbursement rates on a high-earning...
2 weeks ago
Regeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watch
Investopedia
Regeneron shares were lower in premarket trading Thursday after the DOJ filed a complaint accusing the drugmaker of fraudulent price...
2 weeks ago
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
BioSpace
While the VC fund launched on Monday by Regeneron Pharmaceuticals has an investment mandate that includes healthcare broadly, Regeneron...
1 week ago
Justice Dept. accuses Regeneron of manipulating Medicare pricing - STAT
STAT
The Justice Department claims Regeneron greatly inflated the costs of its drug to Medicare over many years and enhanced its revenues.
2 weeks ago